Cardiovascular Systems, Inc. Presenting ORBIT II Study One-Year Coronary Data During 2014 American College of Cardiology Conference

Published: Mar 26, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will feature one-year data from the ORBIT II study of the company’s Diamondback 360® Coronary Orbital Atherectomy System. The study, which is one of the first to investigate treating severely calcified lesions, will be presented at the 2014 American College of Cardiology (ACC) conference in Washington, D.C., Mar. 29–31, 2014. This data, along with physician presentations that include case studies and commercial data, are part of CSI’s series of in-booth live talks at ACC.

Help employers find you! Check out all the jobs and post your resume.

Back to news